Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions
NCT ID: NCT06643507
Last Updated: 2024-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE2/PHASE3
26 participants
INTERVENTIONAL
2024-11-20
2026-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Patient Morbidity and Root Coverage Outcomes of VISTA Versus CAF in Treating Gingival Recession
NCT06723314
Clinical Evaluation of the Amount of Root Coverage Following The Use of VISTA Technique Versus Coronally Advanced Flap in Combination With Subepithelial Connective Tissue Graft for Management of Multiple Gingival Recessions
NCT03340987
Comparison of Using Collagen Membrane and A-PRF Using VISTA Technique in Gingival Recession Treatment
NCT06357351
Clinical Evaluation of Injectable Alb-PRF in the Management of Intrabony Defect in Stage-III Periodontitis Patients
NCT06297577
Effectiveness of the Papillary Extended Connective Tissue Graft in Miller Class III Gingival Recession
NCT03416673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with gingival recession control group
patients with gingival recessions of miller class III /RT2 the control group will be treated with modified vista technique using connective tissue graft
Connective tissue graft
regenerative properties
patients with gingival recession interventional group
patients with gingival recessions of miller class III /RT2 the interventional group will be treated with modified vista technique using albumin PRF
ALB-PRF
regenerative properties
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Connective tissue graft
regenerative properties
ALB-PRF
regenerative properties
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tamani Mahmoud Abdullah Fakhri
clinical evaluation of the modified VISTA technique (M-VISTA)using Albumin -platelet rich fibrin (Alb-PRF)versus connective tissue graft (CTG)in the treatment of multiple miller class III/RT2recessions : a randomized clinical trial
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enji EA Ahmed, BDS.MDS.PHD
Role: STUDY_DIRECTOR
Cairo University
Sarah SE Elbanna, BDS.MDS.PHD
Role: STUDY_DIRECTOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PER 3 -3 -1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.